We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Desktop Analyzer Performs Chemical, Turbidimetric Tests, and Immunoassays

By LabMedica International staff writers
Posted on 10 Nov 2010
A desktop analyzer uses innovative technology to allow simultaneous measurement of immunoassays and clinical chemistry parameters, including turbidimetric tests in one sample.

The fully automated, random access analyzer is ideal for medium-sized and small laboratories, and it will provide diagnostic services to hospitals, clinics, and large medical practice facilities.

The analyzer, which is called DRG:Hybrid-XL, is also ideal for high work-load labs performing routine and niche diagnostic parameters on large automatic equipment. More...
Up to 40 tests of different types or 40 times the same test, or up to 20-patient samples can be ordered by the medical practitioner over a wide range of prepackaged tests to serve different specialties, such as gynecology, oncology, prenatal supervision, cardiac markers, infectious diseases, and other common diseases.

DRG (Mountainside, NJ, USA) plans to showcase the new analyzer DRG:Hybrid-XL at MEDICA 2010, which will take place for four days from November 17, 2010 in Düsseldorf, Germany. It will be available for use in summer 2011.

Cyril E. Geacintov Ph.D., founder, CEO, and president of DRG, said, "The DRG:Hybrid-XL will allow laboratories to conduct specific testing on-site,” he says. "This will provide for faster and more accurate test results with greater convenience.”

Related Links:

DRG International Inc.






Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Fusun Can (at left) is developing a test for detecting both resistance and virulence in Klebsiella pneumoniae (Photo courtesy of Koç University)

Rapid Diagnostic Breakthrough Simultaneously Detects Resistance and Virulence in Klebsiella Pneumoniae

Antibiotic resistance is a steadily escalating threat to global healthcare, making common infections harder to treat and increasing the risk of severe complications. One of the most concerning pathogens... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.